KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Assets: 2015-2024

Historic Assets for BeOne Medicines (ONC) over the last 10 years, with Dec 2024 value amounting to $5.9 billion.

  • BeOne Medicines' Assets rose 30.90% to $7.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 billion, marking a year-over-year increase of 30.90%. This contributed to the annual value of $5.9 billion for FY2024, which is 1.99% up from last year.
  • Latest data reveals that BeOne Medicines reported Assets of $5.9 billion as of FY2024, which was up 1.99% from $5.8 billion recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Assets ranged from a high of $8.5 billion in FY2021 and a low of $5.5 billion during FY2022.
  • Moreover, its 3-year median value for Assets was $5.8 billion (2023), whereas its average is $5.7 billion.
  • In the last 5 years, BeOne Medicines' Assets spiked by 247.38% in 2020 and then tumbled by 35.78% in 2022.
  • Yearly analysis of 5 years shows BeOne Medicines' Assets stood at $5.6 billion in 2020, then skyrocketed by 52.40% to $8.5 billion in 2021, then plummeted by 35.78% to $5.5 billion in 2022, then increased by 5.91% to $5.8 billion in 2023, then rose by 1.99% to $5.9 billion in 2024.